Recent Articles

May 21, 2015 1:12 pm
Stephanie Guzowski, Editor
In a first small clinical trial of its kind, researchers harnessed T cells from patients’ own bone marrow to treat multiple myeloma and provide immune protection for up to a year, according to a study published this week in Science Translational Medicine. Read more...
May 20, 2015 12:15 pm
Ryan Bushey, Associate Editor
These patents are being challenged all over the world. Read more...
May 20, 2015 8:54 am
Christopher J. Pace, Ph.D., GlobalData Managing Analyst, Infectious Diseases
Some industry pundits rightfully question the modest protective efficacies of CYD-TDV and RTS,S/AS01. Read more...
May 19, 2015 1:14 pm
Ryan Bushey, Associate Editor
The test will officially be on the market in the U.S. and U.K. later this year. Read more...
May 19, 2015 8:44 am
Valentina Gburcik, Ph.D., Director of Cardiovascular & Metabolic Disorders, GlobalData
The global treatment market for dyslipidemia will more than double in value from $15.4 billion in 2013 to an estimated $37.9 billion by 2023. Read more...
May 18, 2015 4:19 pm
Ryan Bushey, Associate Editor
Endo spent 8.5 billion on the company for a key reasons. Read more...
May 15, 2015 8:47 am
Maura Musciacco, MSc, GlobalData's Director or Neurology and Opthalmology
The company’s latest report states that while this growth will be primarily driven by the potential introduction of four late-stage pipeline agents. Read more...
May 14, 2015 11:47 am
Seth Augenstein, Digital Reporter
Small-cell lung cancer, often caused by smoking, is among the most stubborn diseases in oncology. While it might respond initially to chemotherapy, it often recurs – and comes back even more resistant to treatment. But a new use of a known immunotherapy, bolstering the body’s immune system, is showing some promise against this disease, according to research taking place at the Rutgers Cancer Institute of New Jersey. Read more...
May 14, 2015 11:33 am
Ryan Bushey, Associate Editor
A study conducted by scientists at Australia’s University of Sydney found that a form of vitamin B3 has the potential to lower the chance of developing skin cancer. Read more...
May 13, 2015 9:50 am
Ryan Bushey, Associate Editor
Abbot Laboratories and the Montreal Heart Institute will help the company with this project. Read more..
Subscribe to Drug Discovery & Development